EUVIMEDOpdag EUVIMED
Crossref

Icariin Regulates Acne Pathophysiology and Extracellular Matrix Protein Synthesis: Implications for Acne Vulgaris and Atrophic Acne Scar Management

Dong Hyo Kim, Ji Young Yoon, Jun Hyo Lee iD, Myeong-Woo Nam, Dae Hun Suh

Experimental Dermatology · 2026-07 · 35 (7)

DOI: 10.1111/exd.70310 ↗

At a glance

Journal article in Experimental Dermatology, published online on 2026-06-29. Written by Dong Hyo Kim and 4 co-authors. Institution: Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea. Major MEDLINE topics: Flavonoids, Acne Vulgaris, Extracellular Matrix Proteins, Cicatrix. 54 references. Funded by: National Research Foundation of Korea.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Icariin, the principal active compound of Epimedium species used in traditional East Asian medicine, exhibits anti‐inflammatory and lipid‐regulating effects. However, its effects on human sebocytes and dermal fibroblasts, which could be implicated in the management of acne and atrophic scarring, remain unexplored. This study aimed to evaluate the effects of icariin on human sebocytes, keratinocytes and dermal fibroblasts. Icariin's effects on cell viability, lipid synthesis, inflammation, abnormal keratinization and extracellular matrix (ECM) synthesis were assessed using human SEB‐1 sebocytes, HaCaT keratinocytes and Detroit 551 fibroblasts. Icariin modestly promoted the proliferation of SEB‐1 sebocytes, HaCaT keratinocytes and Detroit 551 fibroblasts. It reduced mRNA levels of lipogenic and proinflammatory markers in SEB‐1 sebocytes and HaCaT keratinocytes. Icariin counteracted arachidonic acid‐induced lipogenesis in SEB‐1 sebocytes in parallel with modulation of the insulin‐like growth factor 1 receptor/Akt signalling pathway. In Detroit 551 fibroblasts, it enhanced ECM protein expression and reduced the expression of ECM‐degrading enzymes, accompanied by upregulation of platelet‐derived growth factor receptor and latent transforming growth factor β binding protein 4. In conclusion, t his study demonstrates that icariin modulates key pathophysiological processes of acne and promotes ECM synthesis, suggesting its potential as a novel therapeutic agent for managing both acne and atrophic acne scars.

Subjects

MeSH terms (MEDLINE)

FlavonoidsAcne VulgarisExtracellular Matrix ProteinsCicatrixHumansFibroblastsLipogenesisKeratinocytesCell ProliferationSignal TransductionCell SurvivalSebaceous GlandsAtrophyReceptor, IGF Type 1Proto-Oncogene Proteins c-akt

Author keywords

acneacne scaricariinlipogenesissebocyte

Substances

FlavonoidsicariinExtracellular Matrix ProteinsReceptor, IGF Type 1Proto-Oncogene Proteins c-akt

Authors and institutions

  • Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Acne, Rosacea, Seborrheic Dermatitis and Hidradenitis Suppurativa Research Laboratory, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Dermatology, Seoul National University Hospital, Seoul, Republic of Korea.

ORCID profiles: Jun Hyo Lee

Funding

  • National Research Foundation of Korea

Cite

APA

Kim, D. H., Yoon, J. Y., Lee, J. H., Nam, M. W., & Suh, D. H. (2026). Icariin Regulates Acne Pathophysiology and Extracellular Matrix Protein Synthesis: Implications for Acne Vulgaris and Atrophic Acne Scar Management. Experimental Dermatology, 35(7). https://doi.org/10.1111/exd.70310

Vancouver

Kim DH, Yoon JY, Lee JH, Nam MW, Suh DH. Icariin Regulates Acne Pathophysiology and Extracellular Matrix Protein Synthesis: Implications for Acne Vulgaris and Atrophic Acne Scar Management. Experimental Dermatology. 2026;35(7). doi:10.1111/exd.70310

BibTeX
@article{Kim2026,
  author = {Kim, Dong Hyo and Yoon, Ji Young and Lee, Jun Hyo and Nam, Myeong-Woo and Suh, Dae Hun},
  title = {Icariin Regulates Acne Pathophysiology and Extracellular Matrix Protein Synthesis: Implications for Acne Vulgaris and Atrophic Acne Scar Management},
  journal = {Experimental Dermatology},
  year = {2026},
  volume = {35},
  number = {7},
  doi = {10.1111/exd.70310}
}
Start for free →